Happy Wednesday! In this week's Big I Buzz, we are giving an update on post-pandemic travel insurance, details about Amazon's new drug subscription service and why you should sign up for a Catalyit Full Access Subscription right now. 

Travel Insurance Sales Remain Elevated Post-Pandemic, But Coverage Demands are Evolving

Squaremouth, Inc., has reported that travel insurance continues to see growth post-pandemic. During COVID-19, demand for travel insurance grew as destinations required coverage and negative COVID-19 tests to gain entry. Now, the reasons for needing travel insurance have evolved. Flight delays, cancellations and lost luggage have plagued airlines over the last few months, and with that Squaremouth saw a 120% increase in search for baggage delay coverage and an 85% increase in policies sold. Policies covering lost luggage saw a 101% increase in sales, while missed connection coverages saw a 138% sales increase. Read more about post-pandemic travel insurance here. 

Amazon Launched a Drug Subscription Service for its Prime Members

For $5 a month, Amazon Prime members can now purchase generic medications. Customers with an active Prime subscription will receive free delivery on their prescriptions. RxPass is currently available in most U.S. states, but heavily populated states are currently excluded - such as California, Pennsylvania and Texas. Kate McCarthy, a Gartner vice president who tracks healthcare stated, "Prices for some individual generic drugs are already cheap, so $5 a month doesn't necessarily represent a discount." Read more about RxPass here. 

Become a Catalyit Full Access Subscriber

Have you heard of Chat GPT-3? Imagine typing in "What is the difference between Collision and Comprehensive Insurance?" Then, in a matter of seconds, watch as an article appears on your screen. Chat GPT-3 is a chatbot created by OpenAi where you can type in a question or prompt and see a written response in seconds. Other capabilities of ChatGPT includes: correcting grammar, write blogs, translate languages, answer questions and write articles. If you want to learn more about ChatGPT's capabilities? Join Catalyit's panel as they explore what ChatGPT-3 can do, what's coming and what to watch out for before jumping in. This webinar is limited to Catalyit Full Access Subscribers, which is FREE for IIAW members. To register for the webinar, you must first become a Catalyit Full Access Subscriber or if you already are, login to the Catalyit website to be able to register for the webinar. 

Read more about Chat GPT-3 here and register for the webinar here. If you are not a Catalyit Full Access Subscriber currently, IIAW members can sign up for free here. 

For more news, check out the Action News section of our weekly e-newsletter, Big I Buzz. If you aren’t subscribed, click here to add your email to our emailing list. Additionally, we send out monthly newsletters with content curated just for you and your role. Make sure you're on the list to receive our communications by heading to bit.ly/industrynewsforyou to stay in the loop!